WU
38
20
CL
45
8
LYB
16
15
ADBE
40
6
EMN
53
15
LEG
28
11
T
53
5
EXR
22
16
MTCH
19
18
OKE
45
15
PVH
35
6
HBAN
59
15
CME
50
14
PH
63
17
HD
43
14
JNPR
60
9
NAVI
30
17
MAS
54
12
DG
27
6
CFG
62
20
WU
38
20
CL
45
8
LYB
16
15
ADBE
40
6
EMN
53
15
LEG
28
11
T
53
5
EXR
22
16
MTCH
19
18
OKE
45
15
PVH
35
6
HBAN
59
15
CME
50
14
PH
63
17
HD
43
14
JNPR
60
9
NAVI
30
17
MAS
54
12
DG
27
6
CFG
62
20
Financhill
Buy
53

CORT Quote, Financials, Valuation and Earnings

Last price:
$67.55
Seasonality move :
2.94%
Day range:
$64.62 - $75.08
52-week range:
$20.84 - $117.33
Dividend yield:
0%
P/E ratio:
58.85x
P/S ratio:
12.27x
P/B ratio:
11.33x
Volume:
2.3M
Avg. volume:
2M
1-year change:
186.61%
Market cap:
$7.7B
Revenue:
$675M
EPS (TTM):
$1.24

Corcept Therapeutics SEC Filings

Company Filed Form Type Description
CORT
Corcept Therapeutics
 05/01/2024 10-Q 10-Q filing on 05/01/2024 View Form
CORT
Corcept Therapeutics
 11/01/2023 10-Q 10-Q filing on 11/01/2023 View Form
CORT
Corcept Therapeutics
 08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
CORT
Corcept Therapeutics
 05/03/2023 10-Q 10-Q filing on 05/03/2023 View Form
CORT
Corcept Therapeutics
 11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
CORT
Corcept Therapeutics
 08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
CORT
Corcept Therapeutics
 05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
CORT
Corcept Therapeutics
 11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
CORT
Corcept Therapeutics
 07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
CORT
Corcept Therapeutics
 05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
CORT
Corcept Therapeutics
 11/03/2020 10-Q 10-Q filing on 11/03/2020 View Form
CORT
Corcept Therapeutics
 08/04/2020 10-Q 10-Q filing on 08/04/2020 View Form
CORT
Corcept Therapeutics
 05/04/2020 10-Q 10-Q filing on 05/04/2020 View Form
CORT
Corcept Therapeutics
 02/24/2020 10-K 10-K filing on 02/24/2020 View Form
CORT
Corcept Therapeutics
 11/07/2019 10-Q 10-Q filing on 11/07/2019 View Form
CORT
Corcept Therapeutics
 08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
CORT
Corcept Therapeutics
 05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
CORT
Corcept Therapeutics
 02/26/2019 10-K 10-K filing on 02/26/2019 View Form
CORT
Corcept Therapeutics
 11/02/2018 10-Q 10-Q filing on 11/02/2018 View Form
CORT
Corcept Therapeutics
 08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
CORT
Corcept Therapeutics
 05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
CORT
Corcept Therapeutics
 02/28/2018 10-K 10-K filing on 02/28/2018 View Form
CORT
Corcept Therapeutics
 11/03/2017 10-Q 10-Q filing on 11/03/2017 View Form
CORT
Corcept Therapeutics
 08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
CORT
Corcept Therapeutics
 05/02/2017 10-Q 10-Q filing on 05/02/2017 View Form
CORT
Corcept Therapeutics
 03/06/2017 10-K 10-K filing on 03/06/2017 View Form
CORT
Corcept Therapeutics
 11/02/2016 10-Q 10-Q filing on 11/02/2016 View Form
CORT
Corcept Therapeutics
 08/03/2016 10-Q 10-Q filing on 08/03/2016 View Form
CORT
Corcept Therapeutics
 05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
CORT
Corcept Therapeutics
 03/10/2016 10-K 10-K filing on 03/10/2016 View Form
CORT
Corcept Therapeutics
 11/06/2015 10-Q 10-Q filing on 11/06/2015 View Form
CORT
Corcept Therapeutics
 08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form
CORT
Corcept Therapeutics
 05/08/2015 10-Q 10-Q filing on 05/08/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get CORT Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

CORT
Sector
P/E ratio
58.85x
22.99x
PEG ratio
1.93x
0.00x
P/B ratio
11.33x
1.53x
Price / LTM sales
12.27x
1.60x

Growth Metrics

CORT
Sector
Revenue growth
34.33%
6.36%
Earnings growth
-7.14%
6.56%
Revenue (5-year growth)
17.11%
8.71%
Earnings forecast
$0.14
-$0.19

Profitability

CORT
Sector
Profitability FY 2024
$664.2M
$55.8M
Return on invested capital
23.78%
-14.46%
Return on assets
19.52%
-11.84%
Return on equity
23.78%
-16.77%

Earnings Date

Last Earnings Date
Feb
26
Next Earnings Date
May
1
Estimated Next Earnings Date
May
28

Balance Sheet

CORT
Sector
Total cash
$383.3M
$41.4M
Short term investments
$255.7M
$37M
Total assets
$840.6M
$124M
Long term debt
--
$10M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Read article
Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Read article
Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Read article

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy or Sell?
Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy or Sell?
Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Buy or Sell?

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 20.01% over the past day.

Buy or Sell?
Sell
31
TECS alert for Apr 10

Direxion Daily Technology Bear 3x Shares [TECS] is up 16.32% over the past day.

Buy or Sell?
Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 16.9% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas